Refine by
Industries served
- Medical / Health Care
- Health and Safety
- Chemical & Pharmaceuticals
- Furniture
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Retail
- Real Estate
- Maritime/Shipbuild/Water Transport
- Communications / Telecom / Datacom
- Oil, Gas & Refineries
- Travel & Leisure
- Agriculture
- Monitoring and Testing
- Environmental
- Air and Climate
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Energy
- Construction & Construction Materials
Pandemic Influenza Suppliers & Manufacturers
11 companies found
based inNorth Syracuse, NEW YORK (USA)
Air Innovations is a world leader in environmental control systems. We specialize in the design and development of self-contained and remote packaged cooling systems. All equipment is produced in our 40,000 square foot, state-of-the-art facility in ...
As a leader in environmental control systems across a variety of industries, Air Innovations understands that the needs of our customers extend well beyond simple control of temperature and humidity. That’s why we developed the ...
based inWashington, DISTRICT OF COLUMBIA (USA)
The American Public Health Association champions optimal, equitable health and well-being for all. With our broad-based member community and 150-year perspective, we influence federal policy to improve the public’s health. APHA serves as a convenor, ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
KIN1148, a small-molecule IRF3 agonist, is a novel influenza vaccine adjuvant found to enhance flu vaccine ...
based inEast Brisbane, AUSTRALIA
Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...
We have created a highly accurate digital test, which enables a user to detect influenza in 12 minutes. The Ellume Pandemic Influenza Self-test connects to a user’s smartphone and provides ...
based inMadison, WISCONSIN (USA)
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. The M2SR Vaccine Platform has the potential to revolutionize the $5 billion annual influenza market, with a clinically-tested vaccine ...
based inIndianapolis, INDIANA (USA)
DQE provides practical products and expert support that improves the safety and readiness of the response and healthcare community. DQE has the expertise and resources needed to help hospitals enhance their readiness for an impending crisis – before ...
based inREDWOOD CITY, CALIFORNIA (USA)
EnGen Bio is developing a therapy and vaccine to provide lifetime immunity to Type A flu. We´ve discovered influenza´s ¨Achille´s heel¨ Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a ...
The Type A influenza M1 protein is enveloped by a lipid bilayer where the hemagglutinin (HA), neuraminidase (NA) and M2 proteins are embedded. While it has been believed that M1 is completely protected by the lipid membrane, we have discovered that ...
based inAnn Arbor, MICHIGAN (USA)
BlueWillow Biologics is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented nanoemulsion platform. The platform, originally discovered at the University of ...
BlueWillow’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies using a seasonal influenza vaccine. Several other ongoing BlueWillow programs — including intranasal ...
based inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
Infectious diseases, caused by pathogenic micro organisms, such as bacteria, viruses, parasites or fungi, are responsible for millions of deaths globally each year. Vaccines are estimated to save millions of lives each year. In addition to ...
based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, CSL Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves ...